Intrinsic value of Sientra - SIEN

Previous Close

$19.67

  Intrinsic Value

$0.00

stock screener

  Rating & Target

str. sell

-100%

Previous close

$19.67

 
Intrinsic value

$0.00

 
Up/down potential

-100%

 
Rating

str. sell

We calculate the intrinsic value of SIEN stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Shares outstanding, mln

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  -44.74
  60.00
  54.50
  49.55
  45.10
  41.09
  37.48
  34.23
  31.31
  28.68
  26.31
  24.18
  22.26
  20.53
  18.98
  17.58
  16.32
  15.19
  14.17
  13.26
  12.43
  11.69
  11.02
  10.42
  9.87
  9.39
  8.95
  8.55
  8.20
  7.88
  7.59
Revenue, $m
  21
  59
  91
  137
  198
  280
  385
  517
  678
  873
  1,103
  1,369
  1,674
  2,018
  2,401
  2,823
  3,284
  3,783
  4,319
  4,891
  5,499
  6,142
  6,819
  7,529
  8,272
  9,049
  9,859
  10,702
  11,579
  12,491
  13,440
Variable operating expenses, $m
 
  142
  218
  325
  470
  662
  909
  1,219
  1,599
  2,057
  2,597
  3,221
  3,938
  4,746
  5,647
  6,640
  7,724
  8,898
  10,159
  11,505
  12,935
  14,447
  16,039
  17,710
  19,458
  21,285
  23,190
  25,173
  27,237
  29,383
  31,613
Fixed operating expenses, $m
 
  10
  10
  11
  11
  11
  11
  12
  12
  12
  12
  13
  13
  13
  14
  14
  14
  14
  15
  15
  15
  16
  16
  16
  17
  17
  18
  18
  18
  19
  19
Total operating expenses, $m
  61
  152
  228
  336
  481
  673
  920
  1,231
  1,611
  2,069
  2,609
  3,234
  3,951
  4,759
  5,661
  6,654
  7,738
  8,912
  10,174
  11,520
  12,950
  14,463
  16,055
  17,726
  19,475
  21,302
  23,208
  25,191
  27,255
  29,402
  31,632
Operating income, $m
  -40
  -93
  -137
  -199
  -282
  -393
  -535
  -713
  -932
  -1,196
  -1,507
  -1,864
  -2,277
  -2,742
  -3,260
  -3,831
  -4,455
  -5,130
  -5,855
  -6,629
  -7,452
  -8,321
  -9,236
  -10,197
  -11,203
  -12,253
  -13,349
  -14,489
  -15,676
  -16,910
  -18,193
EBITDA, $m
  -39
  -86
  -128
  -186
  -266
  -371
  -506
  -675
  -883
  -1,133
  -1,428
  -1,770
  -2,162
  -2,603
  -3,095
  -3,638
  -4,229
  -4,870
  -5,558
  -6,294
  -7,074
  -7,900
  -8,769
  -9,681
  -10,635
  -11,633
  -12,672
  -13,755
  -14,882
  -16,053
  -17,271
Interest expense (income), $m
  0
  2
  7
  12
  20
  31
  46
  64
  87
  116
  150
  191
  238
  292
  353
  420
  495
  577
  665
  759
  861
  968
  1,082
  1,201
  1,327
  1,458
  1,596
  1,739
  1,888
  2,043
  2,204
Earnings before tax, $m
  -40
  -96
  -144
  -211
  -303
  -424
  -581
  -778
  -1,020
  -1,312
  -1,657
  -2,055
  -2,515
  -3,034
  -3,613
  -4,252
  -4,950
  -5,706
  -6,519
  -7,389
  -8,312
  -9,289
  -10,318
  -11,399
  -12,530
  -13,712
  -14,944
  -16,228
  -17,564
  -18,953
  -20,397
Tax expense, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Net income, $m
  -40
  -96
  -144
  -211
  -303
  -424
  -581
  -778
  -1,020
  -1,312
  -1,657
  -2,055
  -2,515
  -3,034
  -3,613
  -4,252
  -4,950
  -5,706
  -6,519
  -7,389
  -8,312
  -9,289
  -10,318
  -11,399
  -12,530
  -13,712
  -14,944
  -16,228
  -17,564
  -18,953
  -20,397

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  67
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  114
  149
  231
  345
  501
  707
  972
  1,305
  1,713
  2,205
  2,785
  3,458
  4,228
  5,096
  6,063
  7,129
  8,293
  9,552
  10,906
  12,352
  13,887
  15,510
  17,219
  19,012
  20,890
  22,851
  24,895
  27,025
  29,240
  31,544
  33,939
Adjusted assets (=assets-cash), $m
  47
  149
  231
  345
  501
  707
  972
  1,305
  1,713
  2,205
  2,785
  3,458
  4,228
  5,096
  6,063
  7,129
  8,293
  9,552
  10,906
  12,352
  13,887
  15,510
  17,219
  19,012
  20,890
  22,851
  24,895
  27,025
  29,240
  31,544
  33,939
Revenue / Adjusted assets
  0.447
  0.396
  0.394
  0.397
  0.395
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
Average production assets, $m
  5
  41
  63
  94
  136
  192
  264
  354
  465
  599
  756
  939
  1,148
  1,384
  1,647
  1,937
  2,253
  2,595
  2,963
  3,355
  3,772
  4,213
  4,678
  5,165
  5,675
  6,208
  6,763
  7,341
  7,943
  8,569
  9,220
Working capital, $m
  72
  23
  35
  53
  76
  108
  148
  199
  261
  336
  425
  527
  645
  777
  924
  1,087
  1,264
  1,456
  1,663
  1,883
  2,117
  2,365
  2,625
  2,899
  3,185
  3,484
  3,796
  4,120
  4,458
  4,809
  5,174
Total debt, $m
  0
  65
  122
  202
  311
  455
  641
  874
  1,160
  1,504
  1,910
  2,381
  2,920
  3,527
  4,204
  4,951
  5,765
  6,647
  7,595
  8,607
  9,681
  10,817
  12,014
  13,269
  14,583
  15,956
  17,387
  18,878
  20,429
  22,041
  23,717
Total liabilities, $m
  31
  105
  162
  242
  351
  495
  680
  913
  1,199
  1,543
  1,949
  2,421
  2,959
  3,567
  4,244
  4,990
  5,805
  6,687
  7,634
  8,646
  9,721
  10,857
  12,053
  13,309
  14,623
  15,995
  17,427
  18,917
  20,468
  22,081
  23,757
Total equity, $m
  84
  45
  69
  104
  150
  212
  292
  391
  514
  661
  835
  1,037
  1,268
  1,529
  1,819
  2,139
  2,488
  2,866
  3,272
  3,706
  4,166
  4,653
  5,166
  5,704
  6,267
  6,855
  7,469
  8,107
  8,772
  9,463
  10,182
Total liabilities and equity, $m
  115
  150
  231
  346
  501
  707
  972
  1,304
  1,713
  2,204
  2,784
  3,458
  4,227
  5,096
  6,063
  7,129
  8,293
  9,553
  10,906
  12,352
  13,887
  15,510
  17,219
  19,013
  20,890
  22,850
  24,896
  27,024
  29,240
  31,544
  33,939
Debt-to-equity ratio
  0.000
  1.450
  1.760
  1.950
  2.070
  2.150
  2.200
  2.230
  2.260
  2.270
  2.290
  2.300
  2.300
  2.310
  2.310
  2.310
  2.320
  2.320
  2.320
  2.320
  2.320
  2.320
  2.330
  2.330
  2.330
  2.330
  2.330
  2.330
  2.330
  2.330
  2.330
Adjusted equity ratio
  0.362
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300
  0.300

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -40
  -96
  -144
  -211
  -303
  -424
  -581
  -778
  -1,020
  -1,312
  -1,657
  -2,055
  -2,515
  -3,034
  -3,613
  -4,252
  -4,950
  -5,706
  -6,519
  -7,389
  -8,312
  -9,289
  -10,318
  -11,399
  -12,530
  -13,712
  -14,944
  -16,228
  -17,564
  -18,953
  -20,397
Depreciation, amort., depletion, $m
  1
  7
  9
  12
  17
  22
  30
  39
  50
  63
  79
  94
  115
  138
  165
  194
  225
  259
  296
  336
  377
  421
  468
  516
  567
  621
  676
  734
  794
  857
  922
Funds from operations, $m
  -36
  -89
  -134
  -198
  -286
  -402
  -551
  -739
  -970
  -1,249
  -1,578
  -1,961
  -2,400
  -2,895
  -3,448
  -4,058
  -4,724
  -5,447
  -6,223
  -7,053
  -7,935
  -8,868
  -9,850
  -10,882
  -11,962
  -13,091
  -14,268
  -15,494
  -16,769
  -18,096
  -19,475
Change in working capital, $m
  -2
  9
  12
  17
  24
  31
  40
  51
  62
  75
  88
  103
  117
  132
  147
  163
  177
  192
  206
  220
  234
  247
  261
  273
  286
  299
  312
  325
  338
  351
  365
Cash from operations, $m
  -34
  -97
  -147
  -216
  -310
  -433
  -591
  -790
  -1,032
  -1,324
  -1,667
  -2,064
  -2,517
  -3,028
  -3,596
  -4,220
  -4,902
  -5,639
  -6,430
  -7,274
  -8,169
  -9,115
  -10,111
  -11,155
  -12,248
  -13,390
  -14,580
  -15,818
  -17,107
  -18,447
  -19,840
Maintenance CAPEX, $m
  0
  -3
  -4
  -6
  -9
  -14
  -19
  -26
  -35
  -47
  -60
  -76
  -94
  -115
  -138
  -165
  -194
  -225
  -259
  -296
  -336
  -377
  -421
  -468
  -516
  -567
  -621
  -676
  -734
  -794
  -857
New CAPEX, $m
  -1
  -16
  -22
  -31
  -42
  -56
  -72
  -90
  -111
  -133
  -158
  -183
  -209
  -236
  -263
  -290
  -316
  -342
  -368
  -393
  -417
  -441
  -464
  -487
  -510
  -533
  -555
  -578
  -602
  -626
  -650
Cash from investing activities, $m
  -13
  -19
  -26
  -37
  -51
  -70
  -91
  -116
  -146
  -180
  -218
  -259
  -303
  -351
  -401
  -455
  -510
  -567
  -627
  -689
  -753
  -818
  -885
  -955
  -1,026
  -1,100
  -1,176
  -1,254
  -1,336
  -1,420
  -1,507
Free cash flow, $m
  -47
  -115
  -173
  -253
  -361
  -503
  -683
  -907
  -1,179
  -1,504
  -1,884
  -2,323
  -2,820
  -3,378
  -3,997
  -4,675
  -5,412
  -6,206
  -7,057
  -7,962
  -8,922
  -9,933
  -10,996
  -12,110
  -13,275
  -14,490
  -15,756
  -17,073
  -18,443
  -19,867
  -21,347
Issuance/(repayment) of debt, $m
  0
  40
  57
  80
  109
  144
  185
  233
  286
  344
  406
  471
  539
  608
  677
  746
  815
  882
  948
  1,012
  1,075
  1,136
  1,196
  1,255
  1,314
  1,373
  1,431
  1,491
  1,551
  1,613
  1,676
Issuance/(repurchase) of shares, $m
  2
  113
  168
  245
  349
  486
  660
  877
  1,142
  1,459
  1,831
  2,257
  2,746
  3,294
  3,903
  4,571
  5,299
  6,084
  6,926
  7,822
  8,773
  9,776
  10,831
  11,937
  13,093
  14,300
  15,558
  16,867
  18,228
  19,644
  21,115
Cash from financing (excl. dividends), $m  
  2
  153
  225
  325
  458
  630
  845
  1,110
  1,428
  1,803
  2,237
  2,728
  3,285
  3,902
  4,580
  5,317
  6,114
  6,966
  7,874
  8,834
  9,848
  10,912
  12,027
  13,192
  14,407
  15,673
  16,989
  18,358
  19,779
  21,257
  22,791
Total cash flow (excl. dividends), $m
  -46
  38
  52
  72
  97
  127
  163
  204
  249
  299
  353
  406
  464
  523
  583
  643
  702
  760
  816
  872
  926
  979
  1,031
  1,082
  1,132
  1,183
  1,233
  1,284
  1,336
  1,389
  1,444
Retained Cash Flow (-), $m
  35
  -113
  -168
  -245
  -349
  -486
  -660
  -877
  -1,142
  -1,459
  -1,831
  -2,257
  -2,746
  -3,294
  -3,903
  -4,571
  -5,299
  -6,084
  -6,926
  -7,822
  -8,773
  -9,776
  -10,831
  -11,937
  -13,093
  -14,300
  -15,558
  -16,867
  -18,228
  -19,644
  -21,115
Prev. year cash balance distribution, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  7
  11
  17
  25
  37
  52
  71
  96
  126
  162
  204
  253
  310
  373
  444
  522
  608
  700
  799
  905
  1,017
  1,136
  1,261
  1,393
  1,530
  1,674
  1,824
  1,980
  2,142
  2,311
Cash available for distribution, $m
 
  -75
  -116
  -173
  -252
  -359
  -497
  -674
  -893
  -1,160
  -1,478
  -1,851
  -2,282
  -2,771
  -3,320
  -3,929
  -4,597
  -5,324
  -6,109
  -6,951
  -7,847
  -8,797
  -9,800
  -10,855
  -11,961
  -13,117
  -14,324
  -15,583
  -16,892
  -18,255
  -19,671
Discount rate, %
 
  4.30
  4.52
  4.74
  4.98
  5.23
  5.49
  5.76
  6.05
  6.35
  6.67
  7.00
  7.35
  7.72
  8.11
  8.51
  8.94
  9.39
  9.86
  10.35
  10.87
  11.41
  11.98
  12.58
  13.21
  13.87
  14.56
  15.29
  16.05
  16.86
  17.70
PV of cash for distribution, $m
 
  -72
  -106
  -151
  -208
  -278
  -361
  -455
  -558
  -666
  -775
  -879
  -974
  -1,054
  -1,114
  -1,153
  -1,168
  -1,158
  -1,125
  -1,070
  -997
  -910
  -813
  -711
  -609
  -510
  -418
  -334
  -261
  -199
  -148
Current shareholders' claim on cash, %
  100
  71.3
  51.9
  38.3
  28.6
  21.6
  16.5
  12.7
  9.8
  7.7
  6.0
  4.7
  3.7
  3.0
  2.4
  1.9
  1.5
  1.2
  1.0
  0.8
  0.6
  0.5
  0.4
  0.3
  0.3
  0.2
  0.2
  0.1
  0.1
  0.1
  0.1

Sientra, Inc. is a medical aesthetics company. The Company's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. Its breast implants are primarily used in elective procedures, which are generally performed on a cash-pay basis. TRUE Texture provides texturing on the implant shell that is designed to reduce the incidence of malposition, rotation and capsular contracture. The Company also offers breast tissue expanders and a range of other aesthetic and specialty products. The Company offers a range of HSC+ breast implants, including anatomically shaped textured, round textured and round smooth. The Company also offers miraDry system, the device to reduce underarm sweat, odor and permanently reduce hair of all colors.

FINANCIAL RATIOS  of  Sientra (SIEN)

Valuation Ratios
P/E Ratio -9.1
Price to Sales 17.4
Price to Book 4.4
Price to Tangible Book
Price to Cash Flow -10.8
Price to Free Cash Flow -10.5
Growth Rates
Sales Growth Rate -44.7%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 0%
Cap. Spend. - 3 Yr. Gr. Rate NaN%
Financial Strength
Quick Ratio NaN
Current Ratio 0
LT Debt to Equity 0%
Total Debt to Equity 0%
Interest Coverage 0
Management Effectiveness
Return On Assets -31.4%
Ret/ On Assets - 3 Yr. Avg. -21.1%
Return On Total Capital -39.4%
Ret/ On T. Cap. - 3 Yr. Avg. -27%
Return On Equity -39.4%
Return On Equity - 3 Yr. Avg. -29.2%
Asset Turnover 0.2
Profitability Ratios
Gross Margin 66.7%
Gross Margin - 3 Yr. Avg. 70.4%
EBITDA Margin -185.7%
EBITDA Margin - 3 Yr. Avg. -99.1%
Operating Margin -190.5%
Oper. Margin - 3 Yr. Avg. -102.1%
Pre-Tax Margin -190.5%
Pre-Tax Margin - 3 Yr. Avg. -103.9%
Net Profit Margin -190.5%
Net Profit Margin - 3 Yr. Avg. -103.9%
Effective Tax Rate 0%
Eff/ Tax Rate - 3 Yr. Avg. 0%
Payout Ratio 0%

SIEN stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the SIEN stock intrinsic value calculation we used $37 million for the last fiscal year's total revenue generated by Sientra. The default revenue input number comes from 2016 income statement of Sientra. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our SIEN stock valuation model: a) initial revenue growth rate of 60% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 4.3%, whose default value for SIEN is calculated based on our internal credit rating of Sientra, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Sientra.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of SIEN stock the variable cost ratio is equal to 243.6%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $10 million in the base year in the intrinsic value calculation for SIEN stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 10% for Sientra.

Corporate tax rate of 27% is the nominal tax rate for Sientra. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the SIEN stock is equal to 18.5%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for SIEN are equal to 68.6%.

Life of production assets of 10 years is the average useful life of capital assets used in Sientra operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for SIEN is equal to 38.5%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $28 million for Sientra - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 19 million for Sientra is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Sientra at the current share price and the inputted number of shares is $0.4 billion.

RELATED COMPANIES Price Int.Val. Rating
MDXG MiMedx Group 3.22 7.68  hold
JNJ Johnson&Johnso 124.69 126.96  hold
CUTR Cutera 43.00 80.73  str.buy
SSKN Strata Skin Sc 1.83 0.17  str.sell

COMPANY NEWS

▶ Sientra: 1Q Earnings Snapshot   [May-09-18 05:18PM  Associated Press]
▶ Sientra Commences Public Offering of Common Stock   [Apr-30-18 07:01AM  GlobeNewswire]
▶ Sientra Receives FDA Approval of PMA Supplement   [Apr-18-18 04:01PM  GlobeNewswire]
▶ Sientra reports 4Q loss   [Mar-13-18 04:19PM  Associated Press]
▶ Sientra, Inc. to Host Earnings Call   [12:00PM  ACCESSWIRE]
▶ ETFs with exposure to Sientra, Inc. : December 7, 2017   [Dec-07-17 02:30PM  Capital Cube]
▶ Sientra reports 3Q loss   [Nov-07-17 05:03PM  Associated Press]
▶ Sientra, Inc. to Host Earnings Call   [10:10AM  ACCESSWIRE]
▶ Sientra® to Release Third Quarter 2017 Financial Results   [Nov-03-17 08:01AM  GlobeNewswire]
▶ ETFs with exposure to Sientra, Inc. : November 2, 2017   [Nov-02-17 12:33PM  Capital Cube]
▶ ETFs with exposure to Sientra, Inc. : October 16, 2017   [Oct-16-17 09:59AM  Capital Cube]
▶ ETFs with exposure to Sientra, Inc. : October 2, 2017   [Oct-02-17 11:06AM  Capital Cube]
▶ ETFs with exposure to Sientra, Inc. : September 19, 2017   [Sep-19-17 06:31PM  Capital Cube]
▶ Sientra reports 2Q loss   [Aug-09-17 04:38PM  Associated Press]
▶ Sientra Announces Settlement of Lawsuit   [Aug-01-17 08:30AM  GlobeNewswire]
▶ Sientra Completes Acquisition of Miramar Labs®   [Jul-26-17 08:30AM  GlobeNewswire]
▶ Sientra to Acquire Miramar Labs®   [Jun-12-17 08:00AM  GlobeNewswire]
▶ ETFs with exposure to Sientra, Inc. : May 30, 2017   [May-30-17 12:43PM  Capital Cube]
▶ ETFs with exposure to Sientra, Inc. : May 15, 2017   [May-15-17 04:38PM  Capital Cube]
▶ Sientra reports 1Q loss   [May-09-17 05:50PM  Associated Press]
▶ ETFs with exposure to Sientra, Inc. : April 7, 2017   [Apr-07-17 05:28PM  Capital Cube]
▶ FDA Links Breast Implants To A Rare Form Of Cancer   [Mar-21-17 05:26PM  Benzinga]
▶ Sientra reports 4Q loss   [Mar-14-17 04:50PM  Associated Press]
▶ Here is What Hedge Funds Think About Sientra Inc (SIEN)   [Dec-14-16 12:54PM  at Insider Monkey]
▶ Sientra to Present at Investor Conferences in November 2016   [Nov-10-16 08:30AM  GlobeNewswire]
Financial statements of SIEN
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.